Business Name: |
Sabnani Indu MD |
Contact Person: |
Indu Sabnani |
Address: |
2130 Millburn Avenue # C11, Maplewood, New Jersey 07040 |
Phone Number: |
(973) 762-7676 |
Website Address: |
lovingcareoncology.com |
Annual Revenue (USD): |
$500.000 to $999.999 |
Location Type: |
Single Location |
Employee Number: |
1 to 4 |
Business Type: |
B2C (Business to Consumer) |
Business Category: |
Doctors |
SIC Code: |
8011 |
NAICS Code: |
6211110 |
Share This Business: |
|
Related Businesses: |
Mendola John V MD - Maplewood, NJ 07040 Rowe Jr Charles A MD - Maplewood, NJ 07040 Dr C Cottrol - Maplewood, NJ 07040 Grinhauz Leo MD - Maplewood, NJ 07040 Gudz Ludmila MD - Maplewood, NJ 07040 Ayyagari K R MD - Maplewood, NJ 07040 Shuttleworth Anne M MD - Maplewood, NJ 07040 Mabry Sharissa B MD - Maplewood, NJ 07040 Burjonrappa Sathyaprasa MD - Maplewood, NJ 07040 Jacobson Sayre K MD - Maplewood, NJ 07040 Bethel Colin A MD - Maplewood, NJ 07040 Wright-Cadet Yvonne MD - Maplewood, NJ 07040 Somer Nancy MD - Maplewood, NJ 07040 Saccone Paul G MD - Maplewood, NJ 07040 Quillen Carl G MD - Maplewood, NJ 07040 Qualter John J DO - Maplewood, NJ 07040 Wallen Marven H MD - Maplewood, NJ 07040 Chrisanderson Donna MD - Maplewood, NJ 07040 Prime Heart - Maplewood, NJ 07040 Flowers Sakhshat W MD - Maplewood, NJ 07040 |
The company Sabnani Indu MD provides B2C services in the form of Doctors from its single location in New Jersey.
1 to 4 employees work for Sabnani Indu MD, and the business now earns $500.000 to $999.999 per annum.
Sabnani Indu MD was launched in 0 and is classified under SIC code and category 8011 , and NAICS number and grouping 6211110 .
To contact Sabnani Indu MD, please call Indu Sabnani with the phone number (973) 762-7676 or visit its single location at 2130 Millburn Avenue # C11 in Maplewood, New Jersey 07040.
The location of the single location can also be found using the coordinates 40.72172,-74.28128.
Read more details about this business on the webpage lovingcareoncology.com or follow the company’s social media accounts, on Twitter and on Facebook.